Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPaypoint Regulatory News (PAY)

Share Price Information for Paypoint (PAY)

Share Price is delayed by 15 minutes
Get Live Data
587.50    -7.00 (-1.18%)
Bid:
583.50
Ask:
585.00
Spread: 1.50 (0.257%)
Market Cap: £352.78m
PAY Live PriceLast checked at - London Stock Exchange

Intraday Paypoint Share Chart

Form 8.3 - PAYPOINT PLC

17 Feb 2023 14:56

RNS Number : 3403Q
Barclays PLC
17 February 2023
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

PAYPOINT PLC

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

16 Feb 2023

(f)

In addition to the company in 1(c) above, is the discloser making

YES:

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

APPRECIATE GROUP PLC

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

1/3p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

124,420

0.18%

114,125

0.17%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

296,642

0.43%

98,567

0.14%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

421,062

0.61%

212,692

0.31%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

1/3p ordinary

Purchase

28

4.8700 GBP

1/3p ordinary

Purchase

30

4.9000 GBP

1/3p ordinary

Purchase

45

4.8900 GBP

1/3p ordinary

Purchase

737

4.8686 GBP

1/3p ordinary

Purchase

970

4.8800 GBP

1/3p ordinary

Sale

369

4.8800 GBP

1/3p ordinary

Sale

385

4.8912 GBP

1/3p ordinary

Sale

467

4.8700 GBP

1/3p ordinary

Sale

1,424

4.8872 GBP

1/3p ordinary

Sale

3,031

4.9004 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

1/3p ordinary

SWAP

Long

385

4.8912 GBP

1/3p ordinary

SWAP

Long

393

4.8799 GBP

1/3p ordinary

CFD

Long

467

4.8693 GBP

1/3p ordinary

SWAP

Long

1,031

4.8899 GBP

1/3p ordinary

CFD

Long

3,031

4.9004 GBP

1/3p ordinary

SWAP

Short

123

4.8902 GBP

1/3p ordinary

CFD

Short

565

4.8800 GBP

1/3p ordinary

CFD

Short

737

4.8686 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercising

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

17 Feb 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETZDLFFXLLEBBZ
Date   Source Headline
9th Feb 20238:30 amRNSForm 8 (DD) - [PayPoint PLC]
8th Feb 20233:30 pmRNSForm 8.3 - APP LN
8th Feb 20233:30 pmRNSForm 8.3 - PAYP LN
8th Feb 20232:37 pmRNSForm 8.3 - PAYPOINT PLC
8th Feb 202311:32 amRNSForm 8.3 - PAYPOINT PLC
8th Feb 20239:04 amRNSForm 8 (DD) - PayPoint PLC
8th Feb 20238:47 amRNSForm 8.5 (EPT/NON-RI) Paypoint Plc
7th Feb 20233:30 pmRNSForm 8.3 - PAYP LN
7th Feb 20233:30 pmRNSForm 8.3 - APP LN
7th Feb 20232:29 pmRNSForm 8.3 - PayPoint plc
7th Feb 202310:20 amRNSForm 8 (DD) - [PayPoint PLC]
7th Feb 20239:24 amRNSForm 8.5 (EPT/NON-RI) Paypoint Plc
6th Feb 20233:30 pmRNSForm 8.3 - APP LN
6th Feb 20233:30 pmRNSForm 8.3 - PAYP LN
6th Feb 20232:55 pmRNSForm 8.3 - Paypoint Plc
6th Feb 20231:06 pmRNSForm 8.3 - PAYPOINT PLC
6th Feb 20239:23 amRNSForm 8 (DD) - PayPoint PLC
6th Feb 20238:52 amRNSForm 8.5 (EPT/NON-RI) Paypoint Plc
3rd Feb 20233:30 pmRNSForm 8.3 - PAY LN
3rd Feb 20233:10 pmRNSForm 8.3 - PayPoint Plc
3rd Feb 20233:07 pmRNSForm 8.3 - PAYPOINT PLC
3rd Feb 202310:07 amRNSForm 8 (DD) - [PayPoint PLC]
3rd Feb 20239:39 amRNSForm 8.5 (EPT/NON-RI) - Paypoint Plc
2nd Feb 20233:30 pmRNSForm 8.3 - PAY LN
2nd Feb 20238:43 amRNSForm 8 (DD) - PayPoint PLC
1st Feb 20233:30 pmRNSForm 8.3 - PAY LN
1st Feb 20233:00 pmRNSForm 8.3 - PayPoint plc
1st Feb 20231:14 pmRNSForm 8 (DD) - [PayPoint PLC]
1st Feb 202310:00 amGNWTotal voting rights
31st Jan 20233:30 pmRNSForm 8.3 - PAY LN
31st Jan 202312:47 pmRNSForm 8 (DD) - [PayPoint PLC]
31st Jan 20237:10 amGNWDirectorate Change
30th Jan 20233:30 pmRNSForm 8.3 - PAY LN
30th Jan 202312:17 pmRNSForm 8.3 - PayPoint plc
30th Jan 20239:22 amRNSForm 8 (DD) - [PayPoint PLC]
27th Jan 202311:22 amRNSForm 8.3 - PayPoint plc
27th Jan 20239:10 amRNSForm 8.5 (EPT/RI)
27th Jan 20239:00 amGNWDirector Declaration
27th Jan 20238:00 amGNWDirector Declaration
26th Jan 202312:48 pmRNSForm 8.3 - PayPoint plc
26th Jan 202312:24 pmRNSForm 8 (DD) - PayPoint PLC
26th Jan 20239:18 amRNSForm 8.5 (EPT/NON-RI) Paypoint Plc
26th Jan 20238:56 amRNSForm 8.5 (EPT/RI)
25th Jan 20234:16 pmRNSForm 8 (DD) - PayPoint PLC
25th Jan 20232:55 pmRNSForm 8.3 - Paypoint Plc
25th Jan 20231:36 pmRNSForm 8 (DD) - PayPoint PLC
25th Jan 202311:50 amRNSNotice of Court Hearing
25th Jan 202310:53 amRNSForm 8.3 - PayPoint PLC
25th Jan 20239:23 amRNSForm 8.5 (EPT/NON-RI) Paypoint Plc
25th Jan 20238:27 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.